Issued Patents All Time
Showing 1–25 of 25 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 8519109 | Tumour rejection antigens | Lan-Qing Huang, Aline Van Pel, Francis Brasseur, Thierry Boon-Falleur | 2013-08-27 |
| 7923534 | Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3 | Thierry Boon, Pierre van der Bruggen, Benoit Van den Eynde, Aline Van Pel, Christophe Lurquin +2 more | 2011-04-12 |
| 7547439 | Tumor rejection antigens | Lan-Qing Huang, Aline Van Pel, Francis Brasseur, Thierry Boon | 2009-06-16 |
| RE40089 | Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor | Thierry Boon-Falleur, Pierre van der Bruggen, Benoit Van den Eynde, Aline Van Pel, Christophe Lurquin +2 more | 2008-02-19 |
| 6669946 | METHOD FOR IDENTIFYING INDIVIDUALS SUFFERING FROM A CELLULAR ABNORMALITY SOME OF WHOSE ABNORMAL CELLS PRESENT COMPLEXES OF HUMAN LEUKOCYTE ANTIGEN TYROSINASE DERIVED PEPTIDES, AND METHODS FOR TREATING SAID INDIVIDUALS | Thierry Boon-Falleur, Vincent Brichard, Aline Van Pel, Pierre Coulie, Jean-Christope Renauld +2 more | 2003-12-30 |
| 6488932 | Method for treating cancer by administering MAGE-derived peptides | Thierry Boon, Pierre van der Bruggen, Christophe Lurquin, Catia Traversari | 2002-12-03 |
| 6379901 | Method for screening for cancer using binders for MAGE related peptides and complexes of the peptide and HLA molecules | Thierry Boon-Falleur, Pierre van der Bruggen, Christophe Lurguin, Catia Traversari, Beatrice Gaugler +1 more | 2002-04-30 |
| 6284476 | Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individuals | Thierry Boon-Falleur, Vincent Brichard, Aline Van Pel, Pierre Coulie, Jean-Christope Renauld +2 more | 2001-09-04 |
| 6221593 | Method for determining cancer by determining expression of MAGE-10 | Thierry Boon-Falleur, Francis Brasseur, Donata Rimoldi | 2001-04-24 |
| 6222012 | Isolated nonapeptides presented by HLA molecules, and uses thereof | Thierry Boon-Falleur, Pierre van der Bruggen, Christoph Lurquin, Catia Traversari, Beatrice Gaugler +2 more | 2001-04-24 |
| 6201111 | Methods for treating subjects with disorders characterized by expression of tumor rejection antigen precursors | Vincent Brichard, Aline Van Pel, Catia Traversari, Thomas Wolfel, Pierre Coulie +1 more | 2001-03-13 |
| 6034214 | Isolated nonapeptides which bind to HLA molecules and provoke lysis by cytolytic T cells | Thierry Boon, Pierre van der Bruggen, Christophe Lurquin, Catia Traversari | 2000-03-07 |
| 6001975 | Precursor processed to at least one tumor rejection antigen presented by HLA-A2 | Vincent Brichard, Aline Van Pel, Catia Traversari, Thomas Wolfel, Thierry Boon-Falleur | 1999-12-14 |
| 5925729 | Tumor rejection antigen precursors, tumor rejection antigens and uses thereof | Thierry Boon, Pierre van der Bruggen, Benoit Van den Eynde, Aline Van Pel, Christophe Lurquin +2 more | 1999-07-20 |
| 5856091 | Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 | Vincent Brichard, Aline Van Pel, Catia Traversari, Thomas Wolfel, Pierre Coulie +1 more | 1999-01-05 |
| 5854203 | Tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 | Vincent Brichard, Aline Van Pel, Catia Traversari, Thomas Wolfel, Thierry Boon-Falleur | 1998-12-29 |
| 5837476 | Methods for determining disorders by assaying for a non-tyrosinase, tumor rejection antigen precursor | Vincent Brichard, Aline Van Pel, Catia Traversari, Thomas Wolfel, Thierry Boon-Falleur | 1998-11-17 |
| 5747271 | Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of HLA-A2/tyrosinase derived peptides, and methods for treating said individuals | Thierry Boon-Falleur, Vincent Brichard, Aline Van Pel, Pierre Coulie, Jean-Christope Renauld +1 more | 1998-05-05 |
| 5695994 | Isolated cytolytic T cells specific for complexes of MAGE related peptides and HLA molecules | Thierry Boon-Falleur, Pierre van der Bruggen, Christophe Lurguin, Catia Traversari, Beatrice Gaugler +1 more | 1997-12-09 |
| 5620886 | Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 | Vincent Brichard, Aline Van Pel, Catia Traversari, Thomas W olfel, Thierry Boon-Falleur | 1997-04-15 |
| 5612201 | Isolated nucleic acid molecules useful in determining expression of a tumor rejection antigen precursor | Thierry Boon-Falleur, Bernard Lethe, Jean-Pierre Szikora, Charles De Smet, Patrick Chomez | 1997-03-18 |
| 5487974 | Method for detecting complexes containing human leukocyte antigen A2 (HLA-A2) molecules and a tyrosinase drived peptide on abnormal cells | Thierry Boon-Falleur, Vincent Brichard, Aline Van Pel, Pierre Coulie, Jean-Christope Renauld +2 more | 1996-01-30 |
| 5462871 | Isolated nucleic acid molecules which encode MAGE derived nonapeptides | Thierry Boon-Falleur, Pierre van der Bruggen, Christophe Lurquin, Catia Traversari, Beatrice Gaugler +1 more | 1995-10-31 |
| 5405940 | Isolated nonapeptides derived from MAGE genes and uses thereof | Thierry Boon, Pierre van der Bruggen, Christophe Lurquin, Catia Traversari | 1995-04-11 |
| 5342774 | Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 | Thierry Boon, Pierre van der Bruggen, Benoit Van den Eynde, Aline Van Pel, Christophe Lurquin +2 more | 1994-08-30 |